Japanese Journal of Clinical Oncology · 2008 · 21 citations · 17 references
Sequential MTX/5-FU therapy provides good survival outcomes with tolerable toxicity despite a limited response in patients with previously treated advanced gastric cancer. This regimen is now being evaluated in a randomized study in patients with pretreated advanced gastric cancer, by the Japan Clinical Oncology Group.
17
Seppo Pyrhönen, Tapio Kuitunen, Paul Nyandoto et al. · British Journal of Cancer · 1995 · 794 citations · Full text
Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao et al. · Journal of Clinical Oncology · 2002 · 431 citations